Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-002462

Director bought 394 shares at an average $4.54 ($1,790)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2021-12-01 Purchase +18 $4.14 $75 14,401 D
Young Caroline Director 2021-12-02 Purchase +18 $3.84 $69 14,419 D
Young Caroline Director 2021-12-03 Purchase +18 $4.47 $80 14,437 D
Young Caroline Director 2021-12-06 Purchase +18 $4.46 $80 14,455 D
Young Caroline Director 2021-12-07 Purchase +18 $5.61 $101 14,473 D
Young Caroline Director 2021-12-08 Purchase +18 $6.15 $111 14,491 D
Young Caroline Director 2021-12-09 Purchase +18 $5.81 $105 14,509 D
Young Caroline Director 2021-12-10 Purchase +18 $4.82 $87 14,527 D
Young Caroline Director 2021-12-13 Purchase +30 $4.36 $131 14,557 D
Young Caroline Director 2021-12-14 Purchase +30 $4.28 $128 14,587 D
Young Caroline Director 2021-12-15 Purchase +30 $4.29 $129 14,617 D
Young Caroline Director 2021-12-16 Purchase +50 $4.53 $227 14,667 D
Young Caroline Director 2021-12-17 Purchase +50 $4.17 $209 14,717 D
Young Caroline Director 2021-12-20 Purchase +60 $4.33 $260 14,777 D
Open-market purchases · 394 sh · avg $4.54 · $1,790
Loading xslF345X03/doc4.xml…